Allakos Inc.

ALLK:NASDAQ

Allakos is a clinical stage biotechnology company developing antibodies that target immunomodulatory receptors present on immune effector cells involved in allergic, inflammatory and proliferative diseases.

streetwise book logo Streetwise Company Fact Sheet

2024/4/25 2:28:37

(ALLK:NASDAQ)